Healthcare technology company System C announced the strategic acquisition of CIS Oncology, marking a significant expansion of its medication management offerings.

CIS Oncology is known for its chemotherapy prescribing and management system, ChemoCare, which accelerates and streamlines prescribing and patient management.

Once integrated, System C customers will be able to manage their entire prescribing journey with a single unified experience through which clinicians and oncologists can prescribe chemotherapy and non-chemotherapeutic medications.

The acquisition of the oncology technology company complements System C’s existing electronic patient records (EPR) portfolio, maternity and neonatal, prescription and pharmacy solutions.

Nick WilsonManaging Director of System C, said: “We are delighted to welcome CIS Oncology to the System C family.

“This acquisition demonstrates our commitment to providing seamless care, prioritizing patient and clinic safety, and forging stronger connections with our customers as they adopt digital solutions in healthcare and social services.

“By integrating the expertise of CIS Oncology, we are now even better equipped to deliver high-quality, cost-effective e-prescribing solutions that not only meet the needs of our customers, but also reinforce our commitment to the NHS and our focused approach on the United Kingdom.

“We look forward to working with CIS Oncology to leverage our collective expertise to significantly transform healthcare and shape the future of patient care.”

CIS Oncology’s cancer informatics solutions streamline data management, enable precision medicine approaches and facilitate coordinated care to give patients personalized treatment plans and support multidisciplinary cancer teams to make informed decisions.

In early 2025, the company plans to launch ChemoPRO, an application that provides patients with instant access to their medical information and allows them to communicate with healthcare professionals.

Tony Pegg, Managing Director of CIS Oncology, said: “CIS Oncology Ltd has always aimed to work with our customers to improve patient outcomes in the safest and most effective way possible.

“Joining forces with System C will strengthen this position through a broader offering to the NHS. We look forward to working together to continue to support the NHS and healthcare providers through further digitalization and ultimately consistently improved patient outcomes.

The C system is actively engaged in Forum Automate 4 Best Care (A4BC)chaired by Lord Carter, to set priorities for medicines interoperability to inform national funding prioritization.

Earlier in 2024, System C announced the launch of its new electronic patient record solution, CareFlow DPEa fully integrated patient record solution that combines patient administration, clinical operations, maternity and neonatal capabilities, pharmacy and prescribing.